TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway
The incidence of papillary thyroid cancer (PTC) has been steadily rising, though the underlying mechanism remains unclear. This study aims to elucidate the biological role of TM4SF4 in the PTC progression. Our differential expression analysis indicated that TM4SF4 was significantly upregulated in PT...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2424570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846126040350457856 |
|---|---|
| author | Lizhi Lin Jialiang Wen Tiansheng Xu Yuhao Si |
| author_facet | Lizhi Lin Jialiang Wen Tiansheng Xu Yuhao Si |
| author_sort | Lizhi Lin |
| collection | DOAJ |
| description | The incidence of papillary thyroid cancer (PTC) has been steadily rising, though the underlying mechanism remains unclear. This study aims to elucidate the biological role of TM4SF4 in the PTC progression. Our differential expression analysis indicated that TM4SF4 was significantly upregulated in PTC, which was corroborated in both our local cohort and the data from Human Protein Atlas. Additionally, clinical characteristics analysis and receiver operating characteristic curves (ROC) demonstrated that TM4SF4 served as a significant diagnostic marker for PTC. Correlation and enrichment analysis of TM4SF4-related partners suggested that it was involved in cell junction and cohesion processes. Furthermore, immune infiltration analysis revealed a positive correlation between TM4SF4 expression and the immune activation in PTC. Importantly, in vitro experiments demonstrated that TM4SF4 downregulation suppressed the proliferation and metastasis of PTC cell lines while inducing apoptosis. We further discovered that the AKT activator SC79 was able to reverse the malignant behaviors suppression caused by TM4SF4 knockdown, suggesting that TM4SF4 may promote PTC progression via the AKT pathway. In conclusion, our study highlights the oncogenic role of TM4SF4 in PTC and identifies it as a novel biomarker for diagnosis and treatment. |
| format | Article |
| id | doaj-art-1ce7eac974744a8e9cd9d13a65ea366b |
| institution | Kabale University |
| issn | 1538-4047 1555-8576 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Cancer Biology & Therapy |
| spelling | doaj-art-1ce7eac974744a8e9cd9d13a65ea366b2024-12-13T06:53:24ZengTaylor & Francis GroupCancer Biology & Therapy1538-40471555-85762024-12-0125110.1080/15384047.2024.2424570TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathwayLizhi Lin0Jialiang Wen1Tiansheng Xu2Yuhao Si3Department of Surgery, Clinical Sciences Lund, Lund University, Lund, SwedenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR ChinaDepartment of Anorectal Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, PR ChinaDepartment of Anorectal Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, PR ChinaThe incidence of papillary thyroid cancer (PTC) has been steadily rising, though the underlying mechanism remains unclear. This study aims to elucidate the biological role of TM4SF4 in the PTC progression. Our differential expression analysis indicated that TM4SF4 was significantly upregulated in PTC, which was corroborated in both our local cohort and the data from Human Protein Atlas. Additionally, clinical characteristics analysis and receiver operating characteristic curves (ROC) demonstrated that TM4SF4 served as a significant diagnostic marker for PTC. Correlation and enrichment analysis of TM4SF4-related partners suggested that it was involved in cell junction and cohesion processes. Furthermore, immune infiltration analysis revealed a positive correlation between TM4SF4 expression and the immune activation in PTC. Importantly, in vitro experiments demonstrated that TM4SF4 downregulation suppressed the proliferation and metastasis of PTC cell lines while inducing apoptosis. We further discovered that the AKT activator SC79 was able to reverse the malignant behaviors suppression caused by TM4SF4 knockdown, suggesting that TM4SF4 may promote PTC progression via the AKT pathway. In conclusion, our study highlights the oncogenic role of TM4SF4 in PTC and identifies it as a novel biomarker for diagnosis and treatment.https://www.tandfonline.com/doi/10.1080/15384047.2024.2424570TM4SF4diagnostic biomarkerpapillary thyroid cancerAKT |
| spellingShingle | Lizhi Lin Jialiang Wen Tiansheng Xu Yuhao Si TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway Cancer Biology & Therapy TM4SF4 diagnostic biomarker papillary thyroid cancer AKT |
| title | TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway |
| title_full | TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway |
| title_fullStr | TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway |
| title_full_unstemmed | TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway |
| title_short | TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway |
| title_sort | tm4sf4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via akt pathway |
| topic | TM4SF4 diagnostic biomarker papillary thyroid cancer AKT |
| url | https://www.tandfonline.com/doi/10.1080/15384047.2024.2424570 |
| work_keys_str_mv | AT lizhilin tm4sf4isadiagnosticbiomarkeracceleratingprogressionofpapillarythyroidcancerviaaktpathway AT jialiangwen tm4sf4isadiagnosticbiomarkeracceleratingprogressionofpapillarythyroidcancerviaaktpathway AT tianshengxu tm4sf4isadiagnosticbiomarkeracceleratingprogressionofpapillarythyroidcancerviaaktpathway AT yuhaosi tm4sf4isadiagnosticbiomarkeracceleratingprogressionofpapillarythyroidcancerviaaktpathway |